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Purpose. To investigate if the peripheral corneal endothelium that is usually discarded after a corneal transplant could be used for
endothelial cell culture. Methods. Donor corneas (n� 19) with a mean age of 72 years, male : female ratio of 15 : 4, and death-to-
preservation time of 10 hours were assessed for endothelial cell density (ECD) and number of dead cells before isolation. Alizarin
red staining (n� 3) was performed to check the morphology of cells in the center and periphery. Descemet’s membrane-en-
dothelial complex was peeled from the center (8.25mm) and the periphery (2.75mm) and plated in two diﬀerent wells of an 8-well
chamber slide with media refreshed every alternate day.*e conﬂuence rate was monitored bymicroscopy. Live/dead analysis was
performed (n� 3) at conﬂuence. Tag-2A12 as a monoclonal antibody against peroxiredoxin-6 (Prdx-6) (n� 4), ZO-1 (zonula
occludens-1) as a tight junction protein (n� 4), and Ki-67 as a proliferative cell marker (n� 4) were used to characterize the cells at
conﬂuence. Results. At conﬂuence, 8.25% average increase in the number of cells was observed from the central zone compared
with 16.5% from the peripheral zone. Proliferation rate, hexagonality, Ki-67 positivity, and the cell area did not signiﬁcantly diﬀer
between the groups (p> 0.05). All the proteins corresponding to the biomarkers tested were expressed in both the groups.
Conclusions. Although there are signiﬁcantly fewer amounts of peripheral cells available after graft preparation for keratoplasty,
these cells can still be used for endothelial cell culture due to their proliferative capability. *e peripheral cells that are discarded
after graft preparation can thus be utilized to increase the donor endothelial cell pool for regenerative treatments.
1. Introduction
Human corneal endothelium is the posterior monolayer of
hexagonal cells that are derived from the neural crest [1, 2].
*ey are nonproliferative in vivo due to their mitotic arrest
[3] and show age-related decrease in cell density [4, 5]. *e
health and viability of these cells must be maintained to
preserve the hydration and transparency of the cornea.
According to the 2016 statistical report of Eye Bank
Association of America (EBAA), approximately 40% of the
keratoplasties performed in the United States were because
of endothelial dysfunction. A global survey reported that
despite several thousand keratoplasties taking place each
year, 12 million patients are still on the waiting list for a
corneal transplant [6]. Hence, it becomes necessary to
identify alternatives that could reduce the demand of human
donor corneas. Several attempts have been made to isolate
and propagate human corneal endothelial cells (HCEnCs)
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and reviewed [7–11]. One successful clinical study has been
reported for the treatment of bullous keratopathy [12] using
cultured cells, so far. *ese studies have been performed
utilizing tissues from young donors. However, most of the
corneas from young donors are transplanted because of high
endothelial cell counts. *us, only old age donor tissues
mostly remain available for cell culture or research.
It has been observed that during keratoplasties like
penetrating keratoplasty (PK), Descemet stripping auto-
mated endothelial keratoplasty (DSAEK), or Descemet
membrane endothelial keratoplasty (DMEK) (including
preloaded DMEK) [13, 14], only the central (usually
7.5mm–8.5mm) zone is used for transplant and the
remaining peripheral tissue is discarded. *ese discarded
peripheral wastes contain a rich zone of putative stem cells
[15]. Several studies have shown that there are more number
of cells in the peripheral endothelium that contain higher
proliferative potential [16–21]. Due to the size of the central
zone used in current keratoplasty procedures, the discarded
peripheral endothelial tissues could be useful in isolating and
culturing the cells. *erefore, we set out to investigate if the
peripheral endothelial cells that are usually discarded after
surgeries like DMEK could be used for endothelial cell
culture, as this may substantially increase the donor en-
dothelial cell pool for regenerative treatments.
2. Materials and Methods
2.1. Ethical Statement. Corneal tissues were collected by the
Veneto Eye Bank Foundation (FBOV, Italy) with written
consent from the donor’s next-of-kin to be used for research
purposes under the guidelines and laws of Centro Nazionale
di Trapianti, Rome, Italy. *e tissues were unsuitable for
transplantation due to the low endothelial cell count
(<2200 cells/mm2). No other complications or indications
were registered.
2.2. Endothelial Cell Count and Donor Characteristics.
Average age, postmortem time, and gender of all the tissues
(n� 19) were recorded retrospectively. *e tissues were
preserved in Cornea Max (Eurobio, Paris, France) at 31°C.
ECD and dead cells were assessed by topical application of
100 μL of 0.25% trypan blue (TB) stain (*ermo Fisher
Scientiﬁc, Rochester, NY, USA), on the corneal endothelium
for approximately 20 seconds and washed with phosphate
buﬀered saline (1X PBS). Dead cells were recorded as the
percentage of trypan blue positive cells (TBPCs). ECD and
TBPCs were recorded before isolation on the cornea using a
calibrated inbuilt eyepiece reticule for the inverted micro-
scope (Axiovert, Zeiss, Germany), both in the center and at
the periphery.*e eyepiece reticule (10×10) was also used to
check the number of cells at conﬂuence and to calculate the
proliferation rate. Average of 5 readings was taken from the
central area and 3 readings from the peripheral area.
2.3. Alizarin Red. *e corneal tissues (n= 3) were washed
removing all the media remnants.*e tissues were placed on
a vacuum block with the endothelium facing the air.
Approximately 250 μL of alizarin red stain (Sigma-Aldrich)
was added on the endothelium, incubated at room tem-
perature (RT) for 3.5minutes, and washed several times with
PBS to remove the excess alizarin red stain. *e tissues were
placed in 1.8% sucrose solution with epithelium facing the
air.*e endothelial cells were viewed and imaged at diﬀerent
areas using an inverted microscope, both in the center and at
the periphery.
2.4. Peeling Method. *e corneal tissues (n� 16) were
washed in sterile PBS. 8.25mm Moria trephine (Moria,
Antony, France) was used to gently tap the endothelial side
creating a superﬁcial cut. It was assured that the blade
trephined an 8.25mm zone as centrally as possible. *e cut
mark was identiﬁed using trypan blue stain (Figure 1(a)).
*e peripheral 2.75mm zone was gently peeled using
120mm acute forceps (e.janach, Como, Italy) (Figure 1(b))
followed by peeling the central 8.25mm zone (Figure 1(c)).
2.5. Media Formulation. *e cell culture medium was a
mixture of HamF12 and M199 (Sigma-Aldrich, St. Louis,
Missouri, USA) (1 :1), supplemented with 5% FBS (Sigma-
Aldrich, St. Louis, Missouri, USA), 1% ascorbic acid (Sigma-
Aldrich, St. Louis, Missouri, USA), 0.5% Insulin-Trans-
ferrin-Selenium (ITS) (*ermo Fisher Scientiﬁc, Waltham,
Massachusetts, USA), recombinant human FGF basic
(10 ng/mL) (*ermo Fisher Scientiﬁc, Waltham, Massa-
chusetts, USA), 10 μM ROCK inhibitor (Y-27632) (Miltenyi
Biotec, Bergisch Gladbach, Germany), and 1% PenStrep
(*ermo Fisher Scientiﬁc, Waltham, Massachusetts, USA)
[9–11].
2.6. Isolation of Cells. *e central and peripheral tissue
pieces were incubated in 2mg/mL collagenase type 1 diluted
in human endothelium-SFM supplemented with 5% FBS
and 1% PenStrep (*ermo Fisher Scientiﬁc, Rochester, NY,
USA) solution for 2 hours at 31°C and 5% CO2. *e cells
collected with collagenase were centrifuged for 5minutes at
1000 rpm. *e supernatant was removed, and the cells were
resuspended with TrypLE express (1X) (Life Technologies,
Monza, Italy) for 10minutes at 37°C to obtain single cells.
*e cells were resuspended with 200 μL of the cell culture
media after counting them using a haemocytometer slide.
2.7. Plating. All the chambers of Lab-Tek II chamber slides
(8 chambers, 25× 75mm, 0.7 cm2 culture area) from
*ermo Fisher Scientiﬁc (Rochester, NY, USA) were coated
with 50 μL of FNC coating mix (cell attachment reagent
(FNC Coating Mix) BRFF AF-10, US Biological Life Sci-
ences, Salem, Massachusetts, USA) for 30minutes at 37°C
and 5% CO2. *e residual coating was removed before
plating the cells. 100 μL of ﬁnal cell suspension was prepared
from both the central and peripheral cells of each donor
cornea. *e cell suspension from the central cornea was
mixed well and added in one chamber of the 8-well chamber
slide and, similarly, the peripheral cells in another chamber
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of the slide. *e cells were not passaged for this study. *e
“number of cells plated” was recorded for all the cultures.
2.8. Morphological Analysis. *e cells from the tissues
(n� 15) were monitored and visualized every alternate day
until conﬂuence using a 10×10 reticule (0.1mm2) attached
to the eyepiece of an inverted microscope (Axiovert, Zeiss,
Germany).*e proliferation rate wasmonitored by counting
the number of boxes ﬁlled with the cells and recorded every
alternate day manually using an eyepiece reticule as de-
scribed above, till conﬂuence.
2.9. Live/DeadAssay. *e cultured cells (n� 3) were washed
with PBS prior to the assay. 3 μL of Hoechst 33342 (H)
(*ermo Fisher Scientiﬁc, Rochester, NY, USA), 2 μL of
ethidium homodimer (EthD-1) (E), and 2 μL Calcein AM
(C) (live/dead viability/cytotoxicity kit, *ermo Fisher
Scientiﬁc, Rochester, NY, USA) were mixed in 1mL of PBS.
100 μL of the ﬁnal solution was directly added on the cul-
tured cells and incubated at RT in the dark for 30minutes.
With the solution still on the cells, HEC was viewed and
imaged within 1 hour using a Nikon Eclipse Ti-E (Nikon,
Burgerweeshuispad, Amsterdam) microscope with NIS El-
ements software (Nikon) [22].
2.10. Immunostaining. *e cultured cells were washed with
PBS and ﬁxed in 4% paraformaldehyde (PFA) at RT for
20minutes. *e cells were permeabilized with 0.5% Triton
X-100 in PBS for 30minutes (note: the permeabilization step
was not performed for 2A12 considering that it is a cell
surface marker and it may damage the epitope). After
blocking with 10% bovine serum albumin (BSA) for 2 hours
at RT, the cells were incubated overnight at 4°C with primary
antibodies such as anti-Ki-67 (n= 4) (1 : 200 (MIB-1, Milan,
Italy)) and anti-2A12 (n= 4) (1 :100 (Tag-2A12)) (Bio-
processing Technology Institute, Singapore) (note: anti-ZO-
1 (n= 4), 1 : 200 (ZO1-1A12, Alexa Fluor 488,*ermo Fisher
Scientiﬁc, Rochester, NY, USA), was only incubated for
3 hours at RT, washed, and analyzed microscopically as it
was already conjugated with Alexa Fluor). *e samples
(except ZO-1) were incubated with goat anti-mouse ﬂuo-
rescein isothiocyanate- (FITC-) conjugated secondary an-
tibody in 5% BSA for 2 hours at RT. After each step, the cells
were washed 3 times with 1X PBS. After removing the wall of
the Lab-Tek slide, the cells were covered with mounting
medium containing 4′,6-diamidino-2-phenylindole (DAPI)
and covered with the cover slips. *e Nikon Eclipse Ti-E
(Nikon, Burgerweeshuispad, Amsterdam) microscope was
used with NIS Elements software (Nikon) to observe the
expression of the proteins and obtain images.
2.11. Measurements and Statistical Analysis. ImageJ (FIJI)
software was used to measure and analyze the data. For ZO-
1, the area was selected and using predeﬁned commands in
Macros for converting the image to overlay masks, the total
number of cells was automatically counted. *e hexagonal
and polymorphic cells were counted based on the cell
structure in the particular area (with 6 borders for hexagonal
cells and less than 4 borders for polymorphic cells). *e
Macros was designed to obtain results by inserting an al-
gorithm in the ImageJ analysis.
*e cell surface area was determined using Calcein AM
by splitting the channels and selecting a cell with a freehand
tool followed by measuring the area with size limits of
150–10,000 μm2.
For Ki-67 positivity, the particles were analyzed using an
outline option to convert the image, and watershed was
applied if necessary. *e percentage of Ki-67 positive cells
was counted based on the number of particles observed in
the area compared with the number of cells counted using
nuclei staining.
*e nonparametricWilcoxon test and Student’s t-test for
paired data using SAS statistical software were employed to
check the statistical signiﬁcance between the central and
peripheral cells, where p< 0.05 was deemed signiﬁcant. A
post hoc correction to the signiﬁcance was applied using the
Bonferroni test.
3. Results
3.1. Donor Characteristics and Cell Numbers. Donor corneas
(n= 19) with a mean age of 71.57± 5.4 years, male : female
(a) (b) (c)
Figure 1: Peel and digest method. (a) After ﬁxing the tissue on a vacuum block, an 8.25mm Moria trephine (Moria, Antony, France) was
used to gently tap the endothelial side on its surface to create a superﬁcial cut, which was identiﬁed using trypan blue staining. (b) *e
peripheral 2.75mm zone was gently detached using 120mm acute forceps (e.janach, Como, Italy), (c) followed by peeling the central
8.25mm zone.
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ratio of 15 : 4, and death-to-preservation time of
10.45± 5.2 hours were used for this study. On the tissues,
ECD in the center (Figure 2(a)) and the periphery
(Figure 2(b)) was observed and recorded. 8.71% (approxi-
mately 150 cells/mm2) average increase in the number of
cells was found from the peripheral zone compared with the
central zone (p< 0.05). Isolated HCEnCs from donors
(n= 1) that did not reach conﬂuence were excluded from this
study. A morphological diﬀerence was observed in the cells
from the central zone (Figure 2(c)) of the cornea compared
with those at the periphery (Figure 2(d)) when viewed using
alizarin red staining. At conﬂuence, 8.25% average increase
in the number of cultured cells was observed from the
central zone compared with 16.5% average increase from the
peripheral zone.
3.2. Proliferation Rate. HCEnCs were observed every al-
ternate day (Figure 3) for morphology, growth pattern, and
proliferation rate.*e average proliferation rate (%) at day 0,
1, 3, 5, 7, and 9 between central and peripheral endothelial
cells was 0, 19, 38, 65, 88, and 99, and 0, 17, 34, 62, 86, and 99,
which was not found to be statistically signiﬁcant
(p � 0.9339) (n� 15).
3.3. Viability Staining (HEC) and Expression of PRDX-6
(2A12), ZO-1, and Ki-67. 100% cell viability (Calcein AM
positivity) was observed in both the groups without any
positivity of ethidium homodimer stain, which stains the
dead cells. From the morphological observation, cell sizes of
HCEnCs from the center (Figure 4(a)) were slightly larger
than HCEnCs from the periphery (Figure 4(b)); however,
the diﬀerence was not signiﬁcant. Expression of PRDX-6
(Tag-2A12) was observed in the cells cultured from the
central zone (Figure 4(c)) and from the periphery of the
cornea (Figure 4(d)). ZO-1 was expressed in the cells from
the center (Figure 4(e)) and from the periphery (Figure 4(f)).
Ki-67 was expressed in both the groups (Figure 4(g): central;
Figure 4(h): periphery).
3.4. Morphology of Cultured Cells. *e cell area was de-
termined on 20 cells per condition using Calcein AM
staining and ImageJ analysis. Diﬀerence in the cell area
(μm2) between the center and the peripheral group was not
found to be statistically signiﬁcant (p � 0.8714), as listed in
Table 1. No signiﬁcant diﬀerence was found in the per-
centage of hexagonality between the cultured center and
peripheral cells (p � 0.5593). *e cells did not show sta-
tistical signiﬁcance in terms of polymorphism (p � 0.7434).
Ki-67 was expressed in both the groups without any sta-
tistical signiﬁcance (p � 0.5813). *e values are listed in
Table 1.
4. Discussion
Replacing the diseased cells of the recipient with that of the
healthy corneal endothelial cells from a cadaveric donor
through common keratoplasty procedures like PK/EK is the
current treatment option for treating endothelial dysfunc-
tion. However, for these keratoplasty techniques, there is a
huge demand of healthy human corneal donor tissues that
are diﬃcult to obtain due to limited supply. *erefore, al-
ternative treatment options such as HCEnC propagation and
transplantation could play an important role as tissue re-
placements [23, 24].
In terms of number of cells, Schimmelpfennig [21] and
Daus et al. [18] reported a signiﬁcant increase in the pe-
ripheral endothelial cell density (ECD) compared with the
central ECD. However, Amann et al. showed regional dif-
ferences in ECD counts between central, paracentral, and
peripheral ECD in normal human corneas [16]. Regional
diﬀerences in proliferative capacity have also been studied
from young (younger than 30 years) and old-aged (older
than 50 years) donor corneas [19]. It is also shown that
HCEnCs cultured from the central and peripheral regions
of a single donor grow in a similar manner [19]. However,
Konomi et al. did not study the proliferative capacity of the
cells from far periphery (9.5mm–11.0mm), which is
available after every suitable graft for transplant. Another
study also indicated that HCEnCs cultured from central
and peripheral regions retain proliferative capacity [20].
Bednarz et al. however showed that HCEnCs from the
peripheral area are able to replicate, but cells from the
center exhibit little to no mitotic activity [17]. Indeed, it has
been observed that cultivated HCEnCs derived from old
donor tissues have lower proliferative capability, a senes-
cent cell phenotype, with enlarged cellular morphology,
which may in turn aﬀect overall cell yield as well as its
inherent functional ability [25]. Old donor tissues, i.e.,
above 65 years of age, are more frequently available for
research as most get rejected due to lower endothelial cell
count that is required for transplantation (data from
FBOV, Italy 2016 annual report) [26]. Expansion and
culturing of HCEnCs from old donor tissues (from the
center and periphery separately) therefore could be ad-
vantageous as it could reduce the waiting time for a suitable
primary source of endothelial cells.
During organ culture preservation, if the tissues are
found unsuitable for transplantation due to poor ECD values
then they are generally discarded or used for research, if
consented. Moreover, from our previous study, we have
noticed that tissues obtained from organ culture media show
successful cell culture [22]. Hence, for this study, we used the
tissues directly from organ culture storage media without
deswelling the tissue.
We have observed that the peripheral cells have a high
proliferative capability. Although the number of plated cells
from the peripheral zone was signiﬁcantly lower than those
from the central zone, the cells did not show any statistical
diﬀerence in terms of characterization and parameters that
were checked. Considering that a normal human cornea is
11mm (cell area of 94.985mm2) in diameter and a routine
DMEK graft is 8.25mm (cell area of 53.429mm2) in di-
ameter, the peripheral tissue of 2.75mm (cell area of
41.556mm2) is wasted per DMEK, depending on the type of
surgery that takes place with speciﬁc diameters. For example,
assuming that in a normal DMEK graft, the number of cells
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counted is 2500 cells/mm2, which is roughly 133,572 cells in
an 8.25mm diameter graft (i.e., area of the graft
(53.429mm2) × number of cells/mm2). Considering a
general 10% increase of cells in the periphery of the same
tissue, the number of cells counted will be 2750 cells/mm2,
which is roughly 114,279 cells in the remaining 2.75mm
peripheral area (i.e., area of the graft (41.556mm2) ×
number of cells/mm2).*e diﬀerence observed between the
central and the peripheral cells would therefore be ap-
proximately 19,300 less number of cells plated from the
peripheral zone. In our study, we found an average of
14,510 cells (this value excludes the number of dead cells)
plated less from the peripheral zone compared with those
from the central zone, which is nearing the hypothetical
value of 19,300 cells. At conﬂuence, the diﬀerence between
the number of cells from the central and peripheral zone
was approximately 200 cells/mm2. However, as the increase
in the number of cells was signiﬁcantly higher from the
peripheral zone, it seems that both the zones can be cul-
tured up to conﬂuence.
Earlier, mostly PK was performed but with recent ad-
vances in the EK procedures, it is now possible to utilize the
far periphery of the endothelium for cell isolation and
proliferation in vitro. *erefore, from this study, we found
two important advantages of culturing a central and/or a
peripheral graft:
(i) *e usually discarded peripheral tissues after sur-
geries like PK, DSAEK, or DMEK could be used in
cell culture facilities to grow another graft and use it
for transplantation. *e ﬁnal cell density at con-
ﬂuence shows a value similar to the transplanted
graft as the proliferative capacity of the peripheral
cells is higher.
(ii) Two complete endothelial grafts can be generated from
a single donor tissue (research grade) discarded from
the transplant due to poor endothelial cell density.
Moreover, as the tissues obtained in this study were from
old age donors, the primary endothelial cell pool increases
due to the discard rate of old age donor tissues. Our protocol
mimics that of the currently used DMEK graft sizes;
therefore, it may also be easy to retrieve these cells without
any further routine modiﬁcations in the eye bank or in the
theatre increasing the donor endothelial cell pool, as the
peripheral 2.75mm zone is rich in proliferative cells [26].
*is study could also open up possibilities of harvesting
cells from patients with small central endothelial de-
compensation, who still have some good cells at the pe-
riphery, to culture and transplant them as an autograft and,
by that, reducing the chances of endothelial rejection. Al-
though there will be two surgical procedures required, if the
central corneal endothelium is able to maintain and not
Central
(a)
Peripheral
(b)
Central
(c)
Peripheral
(d)
Figure 2: Morphology of the endothelial cells on the corneal tissues using diﬀerent staining methods. (a) ECD count in the central region
was lower compared (scale: 100 μm) with (b) ECD in the periphery (scale: 250 μm). (c) Morphology in the center of the cornea (scale:
100 μm) compared with (d) that in its periphery (scale: 100 μm) was observed using alizarin red staining.
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Central Peripheral
Day 0
Day 1
Day 3
Day 5
Day 7
Day 9
250µm 250µm
250µm 250µm
250µm 250µm
250µm 250µm
250µm 250µm
250µm 250µm
Confluence 0% Confluence 0%
Confluence 19% Confluence 17%
Confluence 38% Confluence 34%
Confluence 65% Confluence 62%
Confluence 88% Confluence 86%
Confluence 99% Confluence 99%
Figure 3: Morphology and conﬂuence rate of the HCEnCs at alternate days of culture.
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worsen the edema, then the peripheral cells can be cultured
to conﬂuence and used as an autograft. We have also showed
that peripheral tissues deemed for preloaded DMEK could
successfully be preserved, transported, and cultured in the
lab further increasing the potential of using peripheral grafts
for cell culture [26].
*us, the results reﬂect that if both the zones are cultured
or if the peripheral zone is cultured and the central is
transplanted, almost all the corneas available for transplants
have a potential for providing two full grafts from one donor
eye, depending on the preliminary endothelial cell counts.
*is would substantially increase the donor endothelial cell
pool for regenerative treatments.
Data Availability
All the data are available in the Veneto Eye Bank Foundation
(FBOV, Italy) repository.
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Figure 4: Live/dead analysis using HEC staining. Cell viability was observed in the (a) central and (b) peripheral zone. Expression of PRDX-
6 (Tag-2A12) was observed in the cells cultured from (c) the center of the cornea and from (d) its periphery. ZO-1 was expressed in the cells
from (e) the center and from (f) the periphery. Ki-67 was expressed in (g) the center and (h) the periphery.
Table 1: Cell area, hexagonality, polymorphism, and Ki-67 positivity of the cells cultured from central and peripheral zones.
Cell area (μm2) Hexagonality (%) Polymorphism (%) Ki-67 (%)
Central Peripheral Central Peripheral Central Peripheral Central Peripheral
Average± standard
deviation (range)
407± 16.09
(389–420)
404± 25.06
(380–430)
69.66± 1.53
(68–71)
71.33± 4.04
(67–75)
19.67± 4.73
(16–25)
21± 4.58
(17–26)
7.67± 1.53
(6–9)
8.33± 1.15
(7–9)
p value 0.8713 0.5593 0.7434 0.5813
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